MEMOTEXT provides secure, data-driven digital engagement solutions that boost treatment adherence, simplify care coordination, and maximize outcomes, all while delivering measurable ROI for health systems. Build your own solution or choose from our co-created marketplace.

MEMOTEXT is a platform for co-creation of digital patient engagement and digital therapeutics. We use health data to identify risk and drive personalization of secure, omni-channel treatment adherence, care-coordination and patient support applications.

MEMOTEXT provides secure, interactive digital engagement including SMS messaging, mobile applications, WhatsApp and voice assistants. Create your solution or choose from our marketplace of validated solutions.

Predictive and advanced analytics provide integrated insights into identification of at-risk populations and evidence-informed tailoring of communications content. 

Our empathy-based and evidence-driven expertise has been shown to deliver clinical and commercial improvements in adherence, care-coordination, patient support and readmission reductions. See the outcomes and our co-commercialized marketplace.

MEMOTEXT began as a simple medication adherence web-app. From our users, we realized we needed to make reminders, support and educational content not only engaging but relevant.  Iterating with clients since 2012, we learned to use validated assessments and health data to understand context and  automatically tailor a mobile health intervention that was as unique as its user.

We began by using subjective behavioural assessments (questionnaires) to build tailored and adaptive messaging and mobile health interventions. Over time we started to consume claims data to understand patient medication history and refill dates to provide an objective source for personalizing messaging content. We also started integrating external sources of health data, like ambient phone data (sleep, activity), wearables and EMR data to tailor messaging, notifications, social feeds and voice messages.

Over time we realized that a large part of our strength comes from our ability to enable the visions of those we collaborate with. The most critical asset of a platform is external—the community of stakeholders. 

MEMOTEXT contributes, enables, validates and scales the visions of our collaborators and our clients.  We are very fortunate to have surrounded ourselves with leading academic and clinical innovators to work and collaborate with. We are also fortunate enough to have built a network of innovative clinical organizations that work with us to pilot, integrate and scale innovations into clinical and commercial workflows and ultimately improve outcomes